Roche and the Medicines Patent Pool Sign Agreement to Increase Access to Medicines to Treat CMV infection in HIV-patients, a major cause of Blindness

Roche and the Medicines Patent Pool Sign Agreement to Increase Access to Medicines to Treat CMV infection in HIV-patients, a major cause of Blindness The Medicines Patent Pool and healthcare company Roche today announce an agreement to increase access to Valcyte , a key medicine to treat cytomegalovirus .

http://www.biosciencetechnology.com/news/2013/08/roche-and-medicines-patent-pool-sign-agreement-increase-access-medicines-treat-cmv-infection-hiv-patients-major-cause-blindness